1. Home
  2. RNST vs SUPN Comparison

RNST vs SUPN Comparison

Compare RNST & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RNST

Renasant Corporation

HOLD

Current Price

$37.92

Market Cap

3.5B

Sector

Finance

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$49.76

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNST
SUPN
Founded
1904
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
2.9B
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
RNST
SUPN
Price
$37.92
$49.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
5
Target Price
$43.33
$61.60
AVG Volume (30 Days)
535.1K
649.1K
Earning Date
01-27-2026
02-24-2026
Dividend Yield
2.53%
N/A
EPS Growth
N/A
N/A
EPS
1.84
N/A
Revenue
$775,309,000.00
$681,539,000.00
Revenue This Year
$43.37
$8.32
Revenue Next Year
$13.13
$23.64
P/E Ratio
$19.82
N/A
Revenue Growth
13.04
4.54
52 Week Low
$26.97
$29.16
52 Week High
$40.40
$57.65

Technical Indicators

Market Signals
Indicator
RNST
SUPN
Relative Strength Index (RSI) 63.46 49.13
Support Level $35.14 $49.41
Resistance Level $37.24 $50.55
Average True Range (ATR) 1.02 1.60
MACD 0.14 -0.24
Stochastic Oscillator 97.75 41.06

Price Performance

Historical Comparison
RNST
SUPN

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: